02.05.2019 - French biotech Calixar has signed an exclusive licensing agreement with Regeneron Pharmaceuticals, granting the US company exclusive rights to its technology and expertise to...
Advertising Opportunities Print, Digital & Content Solutions
LinkedIn | X (Twitter)